• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ginkgolic Acid (15:1)

Ginkgolic Acid (15:1)

Product ID G3353
Cas No. 22910-60-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $190.00 In stock
5 mg $462.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ginkgolic acids are found in Ginkgo biloba and exhibit antiviral, antibiotic, and anticancer chemotherapeutic activities. In vitro, ginkgolic acids inhibit HIV protease and suppress HIV infection. Ginkgolic acids also exhibit antibacterial efficacy against both gram positive and gram negative bacteria, including Staphylococcus, Escherichia, and Bacillus. Ginkgolic acids also inhibit fatty acid synthase and exhibit cytotoxicity in breast cancer, lung cancer, and leukemia cells. Additionally, ginkgolic acids induce apoptosis in cancer cells through downregulation of Bcl-2 and upregulation of Bax. Ginkgolic acids may also be neurotoxic, as they increase activity of protein phosphatase 2C (PP2C) in neurons.

Product Info

Cas No.

22910-60-7

Purity

≥98%

Formula

C22H34O3

Formula Wt.

346.50

IUPAC Name

2-hydroxy-6-[(Z)-pentadec-8-enyl]benzoic acid

Synonym

Romanicardic acid, Anacardic acid 15:1, Ginkgolic Acid I

Melting Point

136-137°C

Solubility

Soluble in acetone.

Appearance

White Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G3353 MSDS PDF

Info Sheet

G3353 Info Sheet PDF

Brochures

Antivirals Booklet

References

Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M1444

    MDL 29951

    GPR17 agonist, NMDA and fructose 1,6-bisphospha...

    ≥98%
  • M3377

    Mitomycin C

    Alkaloid produced by Streptomyces, DNA cross-li...

    ≥98%
  • F8150

    Fumonisin B2

    Mycotoxin produced by Fusarium; sphingosine acy...

    ≥97%
  • E4785

    Elvitegravir

    Integrase inhibitor.

    ≥98%
  • O783743

    OTSSP167 Hydrochloride

    MELK inhibitor.

    ≥98%
  • U451349

    Ulixertinib

    May induce apoptosis in lymphoma cell lines.

    ≥98%
  • E7209

    Escitalopram Oxalate

    S-enantiomer of citalopram; SERT inhibitor.

    ≥99%
  • A0818

    15-Acetoxyscirpenol

    Trichothecene mycotoxin produced by Fusarium.

    ≥97%
  • C5647

    Colistin Sulfate

    Polymixin, antimicrobial peptide, induces forma...

    Biological Potency: ≥19366 IU/mg
  • O9256

    16-Oxocafestol

    Synthetic cafestol derivative.

    ≥97%
  • C4656

    Clopidol

    Coccidiostat.

    ≥98%
  • M5793

    Moxifloxacin Free Base

    Fluoroquinolone; topoisomerase IV, topoisomeras...

    ≥98%
  • A9714

    AZD-1152-HQPA

    AurKA/B inhibitor.

    ≥98%
  • E5569

    Enramycin B

    Polypeptide; peptidoglycan inhibitor.

    ≥83%
  • M0114

    Madecassic Acid

    Downregulates LPS-stimulated expression of pro-...

    ≥95%
  • F5870

    N-formyl-Met-Leu-Phe

    Peptide, involved in neutrophil activation; FPR...

    ≥95%
  • T1644

    Telmisartan

    AT-II antagonist, PPARγ/δ modulator.

    ≥98%
  • R5722

    Rofecoxib

    NSAID; COX-2 inhibitor.

    ≥98%
  • I0901

    Icariin

    Flavonol glycoside originally found in Epimediu...

    ≥97%
  • C2800

    Chalcone

    Enone.

    ≥97%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only